SEARCH RESULTS for assignee:"alnylam pharmaceuticals"

Showing 1 to 9 of 9 results

Share this

Reel/Frame

Last Update:

Patent(s)

(X0) 15499981: POLYNUCLEOTIDE AGENTS TARGETING SERPINC1 (AT3) AND METHODS OF USE THEREOF

(A1) 20170240892: POLYNUCLEOTIDE AGENTS TARGETING SERPINC1 (AT3) AND METHODS OF USE THEREOF

(B2) 1: POLYNUCLEOTIDE AGENTS TARGETING SERPINC1 (AT3) AND METHODS OF USE THEREOF

Reel/Frame

Last Update:

Patent(s)

(X0) 15683999: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

(A1) 20170355994: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

(B2) 1: ANGIOPOIETIN-LIKE 3 (ANGPTL3) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Reel/Frame

Last Update:

Patent(s)

(X0) 16054854: Methods of Treating Transthyretin (TTR) Mediated Amyloidosis

(A1) 20190162724: Methods of Treating Transthyretin (TTR) Mediated Amyloidosis

Reel/Frame

Last Update:

Patent(s)

(X0) 15944382: GNAQ Targeted dsRNA Compositions and Methods for Inhibiting Expression

(A1) 20190106694: GNAQ Targeted dsRNA Compositions and Methods for Inhibiting Expression

Reel/Frame

Last Update:

Patent(s)

(X0) 16162705: HIGH DENSITY LIPOPROTEIN BINDING PROTEIN (HDLBP/VIGILIN) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

(A1) 20190038658: HIGH DENSITY LIPOPROTEIN BINDING PROTEIN (HDLBP/VIGILIN) iRNA COMPOSITIONS AND METHODS OF USE THEREOF

Reel/Frame

Last Update:

Patent(s)

(X0) 15221651: TRANSTHYRETIN (TTR) IRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES

(A1) 20170029817: TRANSTHYRETIN (TTR) IRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES

(B2) 1: TRANSTHYRETIN (TTR) IRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING TTR-ASSOCIATED DISEASES

Reel/Frame

Last Update:

Patent(s)

(X0) 15212884: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD274/PD-L1 GENE

(A1) 20170067060: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD274/PD-L1 GENE

(B2) 9: COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF CD274/PD-L1 GENE

Reel/Frame

Last Update:

Patent(s)

(X0) 15596845: COMPOSITIONS FOR NUCLEIC ACID DELIVERY

(A1) 20180369384: COMPOSITIONS FOR NUCLEIC ACID DELIVERY

Reel/Frame

Last Update:

Patent(s)

(X0) 15781747: POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF

(A1) 20180371465: POLYNUCLEOTIDE AGENTS TARGETING PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1) AND METHODS OF USE THEREOF